Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Visser NCM; van der Putten LJM; van Egerschot, A; Van de Vijver, KK; Santacana, M; Bronsert, P; Hirschfeld, M; Colas, E; Gil-Moreno, A; Garcia, A; Mancebo, G; Alameda, F; Krakstad, C; Tangen, IL; Huvila, J; Schrauwen, S; Koskas, M; Walker, F; Weinberger, V; Minar, L; Hausnerova, J; Snijders MPLM; van den Berg-van Erp, S; Matias-Guiu, X; Trovik, J; Amant, F; Massuger LFAG; Bulten, J; Pijnenborg JMA

    Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study

    HUMAN PATHOLOGY 89 90-98. .

    [doi:10.1016/j.humpath.2019.04.014]

  • Baena Fustegueras JA; Gonzalez, FH; Caldero, SG; de la Fuente Juárez MC; Lopez, SR; Riu, FR; Petit, NM; Alvarez, PM; Torello, AL; Matias-Guiu, X; Olsina Kissler JJ

    Magnetic detection of sentinel lymph node in papillary thyroid carcinoma: The MAGIC-PAT study results

    EJSO 45 1175-1181. .

    [doi:10.1016/j.ejso.2019.03.017]

  • Leskela, S; Perez-Mies, B; Rosa-Rosa, JM; Cristobal, E; Biscuola, M; Palacios-Berraquero, ML; Ong, S; Matias-Guiu Guia X; Palacios, J

    Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma

    Cancers 11 -. .

    [doi:10.3390/cancers11070964]

  • Roman-Canal, B; Tarragona, J; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Sierra, JE; Rufas, M; Gonzalez, E; Porcel, JM; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Matias-Guiu, X; Colas, E

    EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer

    Journal Of Translational Medicine 17 208-208. .

    [doi:10.1186/s12967-019-1954-8]

  • Roman-Canal, B; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Gonzalez, E; Gonzalez-Tallada, X; Llordella, I; Hernandez, I; Porcel, JM; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Matias-Guiu, X; Colas, E

    EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer

    Cancers 11 -. .

    [doi:10.3390/cancers11060839]

  • Reijnen, C; van Weelden, WJ; Arts MSJP; Peters, JP; Rijken, PF; van de Vijver, K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Reques, A; Mancebo, G; Krakstad, C; Trovik, J; Haldorsen, IS; Huvila, J; Koskas, M; Weinberger, V; Minar, L; Jandakova, E; Snijders MPLM; van den Berg-van Erp, S; Küsters-Vandevelde HVN; Matias-Guiu, X; Amant, F; ENITEC-consortium; Massuger LFAG; Bussink J; Pijnenborg JMA

    Poor outcome in hypoxic endometrial carcinoma is related to vascular density

    BRITISH JOURNAL OF CANCER 120 1037-1044. .

    [doi:10.1038/s41416-019-0461-2]

  • Trapero, Carla; Vidal, August; Rodriguez-Martinez, Aitor; Sevigny, Jean; Ponce, Jordi; Coroleu, Buenaventura; Matias-Guiu, Xavier; Martin-Satue, Mireia

    The ectonucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in human endometrium: a novel marker of basal stroma and mesenchymal stem cells.

    Purinergic Signalling 15 225-236. .

    [doi:10.1007/s11302-019-09656-3]

  • Pereira-Veiga, T; Abreu, M; Robledo, D; Matias-Guiu, X; Santacana, M; Sanchez, L; Cueva, J; Palacios, P; Abdulkader, I; Lopez-Lopez, R; Muinelo-Romay, L; Costa, C

    CTCs-derived xenograft development in a triple negative breast cancer case

    INTERNATIONAL JOURNAL OF CANCER 144 2254-2265. .

    [doi:10.1002/ijc.32001]

  • Cuevas, D; Valls, J; Gatius, S; Roman-Canal, B; Estaran, E; Dorca, E; Santacana, M; Vaquero, M; Eritja, N; Velasco, A; Matias-Guiu, X

    Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    VIRCHOWS ARCHIV 474 585-598. .

    [doi:10.1007/s00428-018-02516-2]

  • Felip, I; Moiola, CP; Megino-Luque, C; Lopez-Gil, C; Cabrera, S; Sole-Sanchez, S; Muñoz-Guardiola P; Megias-Roda, E; Perez-Montoyo, H; Alfon, J; Yeste-Velasco, M; Santacana, M; Dolcet, X; Reques, A; Oaknin, A; Rodriguez-Freixinos, V; Lizcano, JM; Domènech C; Gil-Moreno, A; Matias-Guiu, X; Colas, E; Eritja, N

    Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

    GYNECOLOGIC ONCOLOGY 153 425-435. .

    [doi:10.1016/j.ygyno.2019.03.002]

  • Mariscal, J; Fernandez-Puente, P; Calamia, V; Abalo, A; Santacana, M; Matias-Guiu, X; Lopez-Lopez, R; Gil-Moreno, A; Alonso-Alconada, L; Abal, M

    Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    JOURNAL OF PROTEOME RESEARCH 18 1043-1053. .

    [doi:10.1021/acs.jproteome.8b00750]

  • Karpathiou, G; Matias-Guiu, X; Mobarki, M; Vermesch, C; Stachowicz, ML; Chauleur, Celine; Peoc'h, M

    Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis

    HUMAN PATHOLOGY 85 309-312. .

    [doi:10.1016/j.humpath.2018.08.015]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU